Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease

Clinical trial NCT04335786 · TERMINATED

Trial details

NCT number: NCT04335786
Sponsor: Radboud University Medical Center
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Respiratory Distress Syndrome SARS-CoV-2 COVID COVID-19 Severe Acute Respiratory Syndrome

Start date: 2020-04-17
Primary completion: 2021-05-25
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.